Advertisements

Stay Awake

Quick links to important sections

Stay Awake

Advertisements

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Stay Awake

Quick Facts

Property Description
Active ingredient Caffeine (1,3,7-trimethylxanthine)
Form Oral Tablet
Pharmacological class Central Nervous System (CNS) Stimulant
Common purpose Temporary Mental Alertness
Origin Isolated Compound

What Type of Medicine is Stay Awake?

Stay Awake is an Alertness Aid that is pharmacologically classified as a Central Nervous System (CNS) Stimulant. The active ingredient in this monosemantic pharmaceutical preparation is Caffeine, which positions the product within the methylxanthine derivative group. Its primary purpose, as an over-the-counter (OTC) medication, is the transient restoration of mental alertness and counteracting general drowsiness. The product is specifically focused on individuals, such as students or drivers, seeking brief periods of temporary wakefulness when fatigue occurs.

Composition and Physical Form

The core of Stay Awake is its sole active ingredient, Caffeine, also known chemically as 1,3,7-trimethylxanthine. The compound is a single, isolated chemical entity, ensuring consistent delivery of the substance. The medication is uniformly presented as an oral tablet, a standardized dosage form comprising the active agent and necessary inert solid pharmaceutical excipients for physical structure. This standardized tablet format differentiates the product from variable caffeine consumption methods, providing a reliable quantity of the stimulant.

How Does Stay Awake Generally Benefit the User?

Stay Awake provides a general benefit by functioning as an adenosine receptor antagonist. This mechanism involves temporarily blocking the action of adenosine, a natural neurotransmitter that signals fatigue and promotes the feeling of tiredness. Interfering with this fatigue signaling pathway provides a transient, controlled boost to the CNS. This action directly supports the user in achieving and sustaining temporary relief from drowsiness and fatigue, primarily by enhancing attentiveness and focus.

Advertisements

What side effects are possible with Stay Awake?

Possible Side Effects and Safety Information

The safety profile of this medicine is based on the documented effects of its active ingredient, Caffeine, a Central Nervous System (CNS) Stimulant. Regulatory documents organize the potential for adverse reactions across several physiological systems, with the occurrence and severity of effects generally being related to the total systemic exposure.

Documented Adverse Reactions by System-Organ Class

The most commonly documented adverse reactions fall into three primary categories as outlined in official regulatory documents:

System Affected Examples of Documented Reactions
Psychiatric Disorders Insomnia, Irritability, Agitation
Nervous System Disorders Nervousness, Tremor
Cardiac Disorders Tachycardia (Rapid Heart Rate), Palpitations

Additional documented effects include general Gastrointestinal Disturbances.

Serious Adverse Reactions and Safety Constraints

The risk of serious adverse reactions is significantly increased when consumption exceeds the labeled quantity. Official safety information highlights the potential for Seizures and severe Cardiovascular Events in cases of acute toxicity or high-dose exposure. The safety profile requires that individuals consider the total intake of the active ingredient from all sources (including other medications, food, and beverages) to mitigate the risk of these more serious outcomes. This systemic exposure rule is a fundamental safety constraint defined in regulatory labeling.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of the active ingredient, caffeine, results primarily in documented signs of Central Nervous System (CNS) hyper-excitation and Cardiovascular instability, as stated in regulatory labeling. Initial manifestations may include effects such as nervousness, restlessness, excitement, nausea, and vomiting. These signs may rapidly progress to severe and life-threatening outcomes.

Documented Severe Manifestations

Official regulatory sources list severe consequences associated with overdose, including neurological events such as convulsions and seizures, and critical cardiovascular complications like tachycardia, ventricular fibrillation, and cardiac arrest. Metabolic abnormalities, specifically hypokalemia (low potassium) and hyperglycemia (high blood glucose), are also officially reported consequences of significant intoxication.

Mandatory Emergency Action

Due to the severity of these documented risks, regulatory authorities mandate that any suspected overdose or the onset of severe symptoms requires immediately seeking medical attention. Users must contact emergency services immediately for life-threatening symptoms. The management of overdose is defined as symptomatic and supportive treatment because official labeling confirms that no specific antidote is known. Hospital monitoring, including continuous observation of cardiac function and electrolyte levels, is required for cases of significant intoxication.

Advertisements

Therapeutic Uses of Stay Awake

What Stay Awake Treats: Main Uses and Benefits

The primary therapeutic role of this product is commonly used in the therapeutic domain of an Alertness Aid to manage the symptoms of temporary mental fatigue and drowsiness.

Core Therapeutic Focus

This medication is generally applied in conditions characterized by periods of transient drowsiness and fatigue that arise from situational factors, such as partial sleep loss or extended wakefulness. It is an appropriate form of short-term symptomatic assistance used to address symptom clusters that include reduced attentiveness, lapses in vigilance, and impaired concentration.

Use Contexts and Patient Benefit

Stay Awake is considered relevant in scenarios where short-term symptomatic assistance is appropriate, such as by students or individuals engaged in demanding activities who experience symptomatic fatigue. This supportive use assists with managing symptoms that interfere with daily comfort, and may help with necessary mental effort and focus. The therapeutic benefit of this product is relevant for: the transient restoration of mental alertness, managing general drowsiness, and addressing symptomatic reductions in vigilance when impaired by fatigue.


QuickFact Block

Quick Fact: Symptomatic Support for Episodic Fatigue
Symptom Domain Reduced cognitive alertness and generalized tiredness
Core Context Short-term management of transient drowsiness
Patient Benefit Supports sustained attention during periods of fatigue

Regulatory References

  1. NIH DailyMed drug label overview
Advertisements

Eligibility and Restrictions for Use

Eligibility for Stay Awake: Official Regulatory Status

The eligibility profile for Stay Awake, an over-the-counter caffeine product, is governed by official government-approved labeling that establishes clear rules for use based on age and pre-existing conditions.

Eligibility Classification Status and Population
Eligible for Use Adults and adolescents mathbf12 years of age and over.
Contraindicated Individuals with known hypersensitivity to caffeine or any component in the formulation.
Prohibited Children under mathbf12 years of age.
Conditional Use Individuals who are pregnant, breastfeeding, or have a history of high blood pressure, glaucoma, or heart disease.

Age-Related Rules

The most specific restriction is the absolute prohibition on use for children under mathbf12 years of age, as stated in the product's official regulatory monograph. Use is permitted only for those mathbf12 years and older.

Condition-Based Restrictions

Regulatory warnings restrict eligibility for certain populations. Individuals with existing medical conditions such as high blood pressure, glaucoma, or heart disease are explicitly instructed to consult a healthcare professional before use. Similarly, pregnancy and breastfeeding are categorized as conditions requiring mandatory professional consultation prior to taking the medicine.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Constraint Type Interacting Agents / Mechanisms
Metabolic Basis CYP1A2 enzyme substrate and sensitive clinical index
Exposure Increase CYP1A2 Inhibitors (e.g., Ciprofloxacin, Fluvoxamine)
Exposure Decrease CYP1A2 Inducers (e.g., Tobacco Smoking, Phenobarbital)
Pharmacodynamic Risk Additive CNS Stimulant effects with other caffeine products

The official regulatory interaction profile for this product is defined primarily by pharmacokinetic interactions resulting from its status as a sensitive substrate of the Cytochrome P450 1A2 (CYP1A2) enzyme. Co-administration with CYP1A2 Inhibitors, such as the antibiotic Ciprofloxacin or the antidepressant Fluvoxamine, is officially documented to decrease the clearance of the active ingredient. This metabolic constraint leads to an increase in the substance's plasma concentrations and half-life. Conversely, co-administration with CYP1A2 Inducers, which include smoking tobacco or medicines like Phenobarbital, increases clearance, which may result in decreased exposure.

A distinct pharmacodynamic interaction is noted through additive effects. Official regulatory warnings advise consumers to limit the concurrent use of caffeine-containing products (including foods and beverages) and other Central Nervous System (CNS) Stimulants to manage the total stimulant load. Furthermore, co-administration with Theophylline may result in an increase in Theophylline blood levels due to metabolic inhibition. While no mandatory timing separation rules are documented for non-prescription use, regulatory cautions regarding altered metabolism and clearance are specific to populations such as preterm neonates with impaired renal or hepatic function. This structure defines the exposure-altering and additive risks noted in regulatory documents.

Advertisements

Mechanism of Action

How Stay Awake Works

Stay Awake acts through several complementary pharmacodynamic mechanisms in the central nervous system, culminating in increased activity within specific ascending arousal pathways.

It primarily engages in neurotransmitter transporter inhibition, binding to the dopamine transporter (DAT). This interaction inhibits the reuptake of dopamine into the presynaptic neuron, resulting in elevated extracellular dopamine concentrations in brain regions critical for arousal.

The drug also modulates pathways associated with vigilance by activating neurons that release the wake-promoting neuropeptides orexin/hypocretin (originating in the hypothalamus) and the neurotransmitter histamine. This activation initiates signaling sequences that propagate throughout the ascending arousal network. Furthermore, Stay Awake alters the balance of major neurotransmitters by decreasing the release of GABA (gamma-aminobutyric acid, the primary inhibitory signal) while simultaneously increasing glutamate (the primary excitatory signal). This dual effect results in a net shift toward heightened central nervous system activity, influencing the sustainment of the wakefulness cycle.

Advertisements

Dosage and Administration Information

How to Use Stay Awake

This section outlines the administration instructions for the Stay Awake (Caffeine 200 mg) oral tablet. These parameters define the specific manner and frequency for appropriate, non-chronic use.

Administration Instructions

The usage of this medication is standardized as follows:

Administration Scope Instruction
Route of Administration The medication is taken orally (swallowed by mouth).
Dosage Form and Strength Oral Tablet, containing 200 mg of Caffeine.
Standard Single Dose 1 tablet (200 mg).
Dosing Frequency The dose should not be repeated more often than every 3 to 4 hours.

Usage Restrictions and Conditions

Specific restrictions regarding the duration of use and the patient population are essential for proper administration.

  • Duration of Use: This product is designated for occasional use only. It is not to be used as a substitute for adequate sleep.
  • Age Restriction: Use is limited to adults and children 12 years of age and over. Do not use in children younger than 12 years of age.
  • Other Conditions: Use of other caffeine-containing products (medications, foods, or beverages) should be limited while using this tablet. The tablet may be taken with or without food.
Advertisements

Recent Clinical Evidence

Evidence for Use in Transient Drowsiness and Fatigue

Research examined the product in contexts related to temporary mental alertness and conditions marked by transient drowsiness and fatigue resulting from partial sleep loss. This purpose was evaluated through numerous Randomized Controlled Trials (RCTs) and summarized in Systematic Reviews. Studies primarily explored outcomes related to Vigilance and Reaction Time using objective tests and subjective reports. Findings describe patterns observed related to temporary changes in alertness during periods of fatigue. The data show patterns related only to the specific conditions under which the research was conducted, meaning research does not determine whether an individual will respond similarly outside of a controlled setting.


Study Populations and Outcomes Examined

Studies monitored specific endpoints reflecting daily functioning, such as the Psychomotor Vigilance Test (PVT). The data show patterns related to performance outcomes observed in studied populations when compared to a non-active control. The research base mostly involved Healthy Adults and Young Adults, particularly those undergoing total or partial Sleep Deprivation protocols, including specific Occupational Groups like shift workers. Research describes how findings may vary depending on the individual's baseline level of habitual use.


Research Limitations and Uncertainties

Evidence is heavily weighted toward research exploring acute, short-term symptom changes, with follow-up durations limited to a few hours. Long-term effects and the impact of sustained, repeated use over weeks or months are not fully established. Furthermore, data for certain groups remain limited; few data are available for older adults, pregnant individuals, or those with underlying health conditions. Research limitations also include findings where evidence quality varies across studies, in part due to broad differences in the doses and administration schedules used by researchers.

Key Studies & References

  1. Caffeine Tablet Drug Labeling (DailyMed entry for OTC Caffeine preparations)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Stay Awake (FAQ)


Q: How quickly does 'Stay Awake' start to work after taking it?

A: Studies on the active ingredient indicate that it is absorbed rapidly and completely into the body. The onset of stimulating effects is typically felt within approximately 45 minutes to one hour after swallowing the oral tablet.


Q: How long do the effects of 'Stay Awake' typically last?

A: The noticeable stimulating effects of a single dose generally subside after about three to four hours. Clinical data on the active ingredient suggest that its half-life, or the time it takes for half the substance to leave the body, is approximately five hours in healthy adults.


Q: Does taking 'Stay Awake' cause jitters or nervousness?

A: Yes, official safety information states that common side effects include nervousness and tremor. These documented effects are the physiological reactions often described by users as feeling like 'the jitters.'


Q: Can 'Stay Awake' mess up my normal sleep schedule later?

A: As a central nervous system stimulant, the active ingredient can cause insomnia, or difficulty sleeping. To minimize potential disruption to your normal sleep schedule, it is generally recommended to avoid consumption in the hours immediately preceding bedtime.


Q: Does 'Stay Awake' interact with common pain relievers like ibuprofen?

A: The primary drug interaction warnings are focused on medicines that affect the CYP1A2 metabolic enzyme. Common non-prescription pain relievers like ibuprofen are typically not listed in official documents as known agents causing significant interaction through this metabolic pathway.


Q: Are there any known interactions between 'Stay Awake' and herbal supplements?

A: The active ingredient is primarily metabolized by the CYP1A2 enzyme. Certain herbal supplements may interact by inhibiting or inducing this enzyme, which has the potential to alter the concentration of the active ingredient in the bloodstream.


Q: Can I take 'Stay Awake' if I already drink coffee daily?

A: Official regulatory warnings advise users to limit the intake of other caffeine-containing products, including beverages like coffee and tea. Limiting concurrent use is advised to manage the total stimulant load and help reduce the potential risk of adverse effects.


Q: Can pregnant or breastfeeding women use 'Stay Awake'?

A: Official product labeling advises individuals who are pregnant or breastfeeding to consult a healthcare professional prior to considering use.


Q: How should 'Stay Awake' be stored?

A: The tablets should be stored at a controlled room temperature, which is approximately 25 C (77 F). It is important to protect the tablets from excessive heat, moisture, and high humidity, and they should be kept securely out of the sight and reach of children and pets.


Q: Is it better to take 'Stay Awake' with food or without?

A: Official administration instructions indicate that the tablet may be taken with or without food. If symptoms like stomach upset or nausea occur, consuming the tablet with food may be considered.


Q: Is 'Stay Awake' the same thing as a caffeine pill?

A: The product is a brand name for an over-the-counter alertness aid. Its sole active ingredient is caffeine, meaning it is chemically equivalent to generic caffeine pills of the same strength.


Q: What happens if I take 'Stay Awake' on an empty stomach?

A: Taking the tablet on an empty stomach may result in faster absorption, which can lead to a quicker onset of stimulating effects. If stomach upset or nausea occurs, some individuals find that taking the tablet with food is helpful.


Q: Are there any foods or drinks I should avoid while using 'Stay Awake'?

A: You should limit or avoid other foods and beverages that contain caffeine, such as energy drinks, chocolate, coffee, and certain teas. This is done to ensure the combined intake remains within appropriate daily limits for the stimulant.


Q: Can teenagers use 'Stay Awake' to study for exams?

A: Official regulatory documents permit the use of the product for temporary mental alertness in individuals who are 12 years of age and over. The label does not provide specific usage recommendations for academic purposes.


Q: Why do people sometimes use 'Stay Awake' before a long drive?

A: The official indication for the product is for the temporary restoration of mental alertness and counteracting drowsiness. These are conditions that frequently occur during long periods of driving.


Q: Are there long-term health concerns associated with regular 'Stay Awake' use?

A: The product is designated for occasional use only, as long-term health effects of sustained, repeated use over months are not fully established in research. Regular, high-dose use of the active ingredient has been associated with the development of tolerance and withdrawal symptoms upon cessation.


Q: How do I know if I'm taking too much 'Stay Awake'?

A: Official warnings state that consumption exceeding the labeled quantity significantly increases the risk of serious adverse reactions. Symptoms potentially indicating acute toxicity include rapid or dangerously erratic heartbeat, seizures, severe vomiting, or disorientation.


Q: What should I do if I forget to take 'Stay Awake' at my usual time?

A: Since this product is typically used only when needed for drowsiness, there may be no fixed dosing schedule. Standard guidance for products used when needed advises against taking two doses simultaneously to compensate for a forgotten dose.


Q: Is it okay to crush or chew 'Stay Awake' tablets?

A: The official administration route is to swallow the tablet whole by mouth. Unless the product labeling explicitly indicates that the tablet is designed to be altered (e.g., chewable or dissolvable), the standard practice is to swallow it intact.


Q: Can 'Stay Awake' make anxiety worse for some people?

A: As a central nervous system stimulant, the product's documented side effects include nervousness, irritability, and agitation. These physiological responses may potentially exacerbate the symptoms of pre-existing anxiety.


Q: Does 'Stay Awake' lose effectiveness over time (tolerance buildup)?

A: Individuals who habitually consume the active ingredient may develop tolerance to its stimulant effects. This means that, with regular use, the medicine may not produce the same level of alertness or effect over time.


Q: Does 'Stay Awake' have an effect on appetite?

A: Loss of appetite is listed in official safety information as a potential side effect associated with the consumption of the active ingredient.


Q: Why do some people experience stomach upset with 'Stay Awake'?

A: Gastrointestinal Disturbances and nausea are documented side effects of the active ingredient. This is generally due to the stimulant effect. If stomach upset occurs, some users find that taking the tablet with food is helpful.


Q: Can I take 'Stay Awake' with my vitamins and minerals?

A: There are no explicit warnings in regulatory documents against combining the product with general vitamins and minerals. The primary interaction warnings are reserved for other stimulants and prescription medicines that significantly affect the CYP1A2 enzyme.


Q: Is 'Stay Awake' suitable for someone with high sensitivity to caffeine?

A: Individuals with a known hypersensitivity, which is a severe allergic reaction, to the active ingredient are strictly contraindicated from using the medicine. Those who are generally sensitive to the effects of caffeine should exercise caution, as official documents list nervousness and agitation as common side effects.


Q: What are the warning signs of a serious side effect from 'Stay Awake'?

A: Warning signs that indicate a serious adverse reaction include signs of a severe allergic reaction, chest pain, a dangerously rapid or irregular heartbeat (cardiac events), or seizures. If any of these signs occur, seeking immediate medical assistance is important.


Q: Does 'Stay Awake' contain any sugar or common allergens?

A: Official labeling lists all active and inactive ingredients in the tablet formulation. However, the label does not explicitly use terms like 'sugar-free' or 'allergen-free,' and known hypersensitivity to any component in the formulation is a stated contraindication.


Q: Can taking 'Stay Awake' affect mood?

A: Yes, official safety documents list Psychiatric Disorders such as irritability and agitation as possible side effects. These are recognized effects on an individual's mood and emotional state.


Q: Is 'Stay Awake' recommended for shift workers?

A: Clinical research has included shift workers as a population studied for the effects of the active ingredient on vigilance and fatigue. However, the product label itself does not provide an explicit recommendation for use by this occupational group.


Q: Is the effect of 'Stay Awake' influenced by body weight?

A: A person's individual factors, such as body weight and metabolic rate, can influence the pharmacokinetics of the active ingredient. These factors can affect how quickly the substance is processed and the intensity of its effects.


Q: Has 'Stay Awake' been studied in clinical trials?

A: The active ingredient in the product has been the subject of extensive research, including numerous Randomized Controlled Trials (RCTs). Studies have evaluated the ingredient's effects on vigilance, reaction time, and fatigue in various study populations.


Q: What is the active ingredient's half-life in 'Stay Awake'?

A: The mean elimination half-life for the active ingredient (caffeine) in the plasma of healthy individuals is estimated to be approximately five hours. This figure can show wide variation depending on specific individual factors.

Advertisements

How should Stay Awake be stored and disposed of?

How to Store and Dispose of Stay Awake?

This information details the storage and disposal requirements for Stay Awake (Caffeine Tablets) as specified in official regulatory labeling.


Official Storage Requirements

Storage Component Requirement
Temperature Store at controlled room temperature, 25 C (77 F), with permitted variations between 15 C and 30 C.
Protection Protect the medicine from excessive heat, moisture, and high humidity. Do not freeze or refrigerate the tablets.
Container Store in the original, closed, tamper-evident container. Do not use the product if the outer package or blister unit is torn or broken.
Child Safety Keep the medicine strictly out of the sight and reach of children and pets.

Disposal Instructions

Unused or expired tablets should not be flushed down a toilet or poured down a drain. Utilize an official drug take-back program when available. If a take-back program is inaccessible, the tablets may be discarded in household trash after being mixed with an undesirable substance, such as dirt or used coffee grounds, and placed into a sealed bag.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Stay Awake found in:

A-Z Index: